Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1971 1
1977 1
1978 3
1980 1
1982 1
1985 2
1986 1
1987 2
1988 7
1989 4
1990 9
1991 7
1992 14
1993 9
1994 15
1995 15
1996 16
1997 18
1998 34
1999 34
2000 46
2001 61
2002 88
2003 88
2004 124
2005 142
2006 163
2007 181
2008 238
2009 210
2010 250
2011 285
2012 331
2013 345
2014 328
2015 294
2016 352
2017 335
2018 385
2019 401
2020 412
2021 401
2022 381
2023 369
2024 359
2025 340
2026 225
2027 1
2028 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,492 results

Results by year

Filters applied: . Clear all
Page 1
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial.
Yau T, Galle PR, Decaens T, Sangro B, Qin S, da Fonseca LG, Karachiwala H, Blanc JF, Park JW, Gane E, Pinter M, Peña AM, Ikeda M, Tai D, Santoro A, Pizarro G, Chiu CF, Schenker M, He A, Chon HJ, Wojcik-Tomaszewska J, Verset G, Wang QQ, Stromko C, Neely J, Singh P, Jimenez Exposito MJ, Kudo M; CheckMate 9DW investigators. Yau T, et al. Among authors: park jw. Lancet. 2025 May 24;405(10492):1851-1864. doi: 10.1016/S0140-6736(25)00403-9. Epub 2025 May 8. Lancet. 2025. PMID: 40349714 Free article. Clinical Trial.
Reply.
Kim YK, Park JW, Curtis JR, Lee EB. Kim YK, et al. Among authors: park jw. Arthritis Rheumatol. 2026 Mar;78(3):770-771. doi: 10.1002/art.43374. Epub 2025 Nov 14. Arthritis Rheumatol. 2026. PMID: 40931855 No abstract available.
Reply.
Kim YK, Park JW, Curtis JR, Lee EB. Kim YK, et al. Among authors: park jw. Arthritis Rheumatol. 2026 Jan;78(1):261-262. doi: 10.1002/art.43278. Epub 2025 Jul 30. Arthritis Rheumatol. 2026. PMID: 40524512 No abstract available.
APOBEC3A drives deaminase mutagenesis in human gastric epithelium.
An Y, Lee JH, Lim J, Youk J, Park S, Park JH, Yi K, Kim T, Nam CH, Lee WH, Oh SA, Bae YJ, Klompstra TM, Lee H, Han J, Lee J, Park JW, Kim JH, Kim H, Snippert H, Koo BK, Ju YS. An Y, et al. Among authors: park jw. Genome Res. 2025 Oct 1;35(10):2158-2172. doi: 10.1101/gr.280338.124. Genome Res. 2025. PMID: 40858362 Free PMC article.
BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant glioma.
Xing YL, Panovska D, Park JW, Grossauer S, Koeck K, Bui B, Nasajpour E, Nirschl JJ, Feng ZP, Cheung P, Habib P, Wei R, Wang J, Thomason W, Monje M, Xiu J, Beck A, Weber KJ, Harter PN, Lim M, Mahaney KB, Prolo LM, Grant GA, Ji X, Walsh KM, Mulcahy Levy JM, Hambardzumyan D, Petritsch CK. Xing YL, et al. Among authors: park jw. Cell Rep Med. 2025 Jun 17;6(6):102183. doi: 10.1016/j.xcrm.2025.102183. Epub 2025 Jun 12. Cell Rep Med. 2025. PMID: 40505659 Free PMC article.
6,492 results